Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant

Direct-acting oral anticoagulants (DOACs) represent the standard for preventing stroke and systemic embolization (SSE) in patients with atrial fibrillation (AF). There is limited information for patients ≥ 80 years. We report a retrospective analysis of AF patients ≥ 80 years prescribed either a US...

Descripción completa

Detalles Bibliográficos
Autores principales: Taoutel, Roy, Ezekowitz, Michael D., Chaudhry, Usman A., Weber, Carly, Hassan, Dana, Gracely, Ed J., Kamareddine, Mohammed H., Horn, Benjamin I., Harper, Glenn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556913/
https://www.ncbi.nlm.nih.gov/pubmed/36246771
http://dx.doi.org/10.1016/j.ijcha.2022.101130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556913/
https://www.ncbi.nlm.nih.gov/pubmed/36246771
http://dx.doi.org/10.1016/j.ijcha.2022.101130

Ejemplares similares